Schedule
New Patients Referring Physicians
Find a Doctor
Patient Portal
Log In Enroll
Careers
Locations
1-888-663-3488
English
English Spanish
Donate

Department Metrics

View the grants and publications from the Biostatistics and Bioinformatics Department.

  • Grants

    • (00014262) Mechanisms of Radioresistance and Strategies for Radiosensitization in Ovarian Clear Cell Carcinoma
      Award Number:
      Sponsor: Nat Institutes of Health
      PI:Mo, Q.
    • Variation in Tumor-Associated Immune Profiles and Colorectal Cancer Outcomes Across Populations of Diverse Ancestral Origins
      Award Number:
      Sponsor: Nat Institutes of Health
      PI:Teer, J.
    • Overcoming Metastatic Spread of Osteosarcoma with RNA Loaded Nanoparticles
      Award Number:
      Sponsor: Nat Institutes of Health
      PI:Yin, V.
    • Next-Generation Biomedical Big Data Platform for Cancer Research and Collaboration Across Florida
      Award Number:
      Sponsor: Florida Biomedical Research Program (FBRP)
      PI:Wang, X.
    • Targeting ER Stress in Pediatric Acute Myeloid Leukemia
      Award Number:
      Sponsor: Florida Biomedical Research Program (FBRP)
      PI:Shaw, T.
    • Deconvolute Key Biological Drivers That Define Subsets of Lethal Prostate Cancer in African American Men
      Award Number:
      Sponsor: US Army
      PI:Berglund, A.
    • Development of Adverse Event (AE) Derived Biomarkers for Predicting Clinical Outcomes in Lung Cancer
      Award Number:
      Sponsor: Nat Institutes of Health
      PI:Chen, D.
    • Epstein-Barr Virus Driven Tonsillar Versus Peripheral B-cell One-Carbon Metabolic Network Remodeling
      Award Number:
      Sponsor: Nat Institutes of Health
      PI:Teng, M.
    • Dissecting Enhancer Function Through Integrative Genomics
      Award Number:
      Sponsor: Nat Institutes of Health
      PI:Teng, M.
    • Metabolic and Molecular Regulation of Myeloid Cell Functions in Brain Cancer
      Award Number:
      Sponsor: Nat Institutes of Health
      PI:Yu, X.
    • Developing a Cancer Galaxy Computational Workbench to Meet Emerging Cancer Data Analysis Needs
      Award Number:
      Sponsor: Nat Institutes of Health
      PI:Goecks, J.

  • Publications

    • Colin-Leitzinger C, Tang YH, Teng M, Gillis N. Ancestry-dependent patterns of somatic mosaicism and clonal hematopoiesis mutations in over 125,000 individuals reveal distinct cancer associations. Hum Genomics. 2025 Dec.19(1):142. Pubmedid: 41331781. Pmcid: PMC12673770.
    • Kim DW, Kim RD, Jimenez MM, Kim Y, Mehta R. A phase II study of trifluridine/tipiracil in combination with ramucirumab in advanced, refractory gastric, or gastroesophageal junction adenocarcinomas. Oncologist. 2025 Dec.30(12). Pubmedid: 41335458. Pmcid: PMC12681051.
    • Tanvetyanon T, Chen DT, Gray JE. Timing of Durvalumab Consolidation and Survival in Non-Small Cell Lung Cancer: A Population-Based Analysis. JCO Oncol Pract. 2025 Dec.OP2500259. Pubmedid: 41370737.
    • Doerfler R, Chen J, Kim C, Smith JD, Harris M, Singh KB, Isett B, Dadey RE, Brown DD, Lee AV, Wang X, Spector ME, Kim S, Sridharan S, Contrera K, Smith K, Reeder C, Lyons M, Luo J, Liu S, Zandberg DP, Skinner HD, Zervantonakis IK, Vujanović L, Ferris RL, Seethala RR, Zevallos JP, Luke JJ, Bao R. Integrating artificial intelligence-driven digital pathology and genomics to establish patient-derived organoids as new approach methodologies for drug response in head and neck cancer. Oral Oncol. 2025 Dec.171:107742. Pubmedid: 41213213.
    • Xu X, Jarajapu V, Chadourne M, Soto-Vargas Z, Ochoa-Rios SL, Jasani N, Wang K, Mecozzi N, Yao J, Yu X, Karreth FA. FRA1 drives melanoma metastasis through an actionable transcriptional network. Oncogene. 2025 Dec.44(50):4895-4909. Pubmedid: 41286309. Pmcid: PMC12669035.
    • Carson TL, Llanos AAM, Fleming K, Pittman S, Pena A, Henderson J, Doerr V, Cooper AJ, Mallory M, Sutton S, Jim HSL. Rationale and study protocol for a pilot study to determine the feasibility and acceptability of a tailored stress management enhanced behavioral weight loss intervention for Black breast cancer survivors with obesity. Contemp Clin Trials. 2025 Dec.159:108113. Pubmedid: 41135815.
    • Hatoum F, Souza GR, Johnson J, Miller J, Fazili A, Pettaway CA, Campbell MT, Neubauer R, Johns A, Mizelle SR, Kim Y, Chadha J, Zhang J, Jameel G, Oschmann E, Dhillon J, Moscu A, Janeway R, Harris W, Lu X, Spiess PE, Chahoud J. Phase 2 study of dostarlimab plus niraparib in stage III-IV recurrent or refractory Penile squamous cell carcinoma. Future Oncol. 2025 Dec.21(28):3619-3627. Pubmedid: 41163621. Pmcid: PMC12674333.
    • Di Meo F, Albano F, Cesarano A, Wang Y, Kale B, Shain K, Silva A, Kurihara N, Tenshin H, Jellyman D, Song X, Ghaffari S, Mesa H, Creelan B, Freeman C, Zhao X, Meads MB, Rodriguez PC, Marino S, Locke F, Hwu P, Roodman D, Mansilla-Soto J, Perna F. Developing SEMA4A-directed CAR T cells to overcome low BCMA antigen density in multiple myeloma. Cancer Cell. 2025 Dec.43(12):2298-2310.e6. Pubmedid: 41072416. Pmcid: PMC12614569.
    • Parker NH, Ramos JD, Tarhini AA, Schell MJ, Egan KM, Kanetsky PA. A Retrospective Cohort Study of Physical Activity and Survival in Patients Treated with Immune Checkpoint Inhibitors. Cancer Epidemiol Biomarkers Prev. 2025 Dec.34(12):2219-2227. Pubmedid: 40971247. Pmcid: PMC12579459.
    • Kazemian E, Mo Q, Matejcic M, Tsai YY, Sobieski D, Li X, Hoogland AI, Crowder SL, Gonzalez BD, Oswald LB, Sleight AG, Nguyen N, Loroña NC, Damerell V, Komrokji KR, Mooney K, Playdon MC, Ulrich CM, Li CI, Shibata D, Toriola AT, Ose J, Peoples AR, Hardikar S, Kahlert C, Siegel EM, Bower JE, Schmit SL, Gigic B, Jim HSL, Figueiredo JC. Genetic predisposition to persistent fatigue after a diagnosis of colorectal cancer. J Natl Cancer Inst. 2025 Dec.117(12):2513-2525. Pubmedid: 40889272. Pmcid: PMC12682389.
    • Rollison DE, Garcia MA, Amorrortu RP, Zhao Y, Mittman B, Turner K, Kirtane K, Soliman H, Byrne MM, Meade C, Gwede CK, Eschrich S, Yin J, Stanley NB, Fuzzell L, Hernandez D, Tapia-Kwan E, Vadaparampil ST. Design of a cluster randomized multi-level intervention to decrease barriers to minority cancer patient referral and enrollment to cancer clinical trials: The ACT WONDER2S study. Contemp Clin Trials. 2025 Nov.158:108096. Pubmedid: 40992541.
    • Selukar S, Yin V, Othus M. Synthetic control arms and other uses of external data in clinical trials for hematological malignancies. Blood Rev. 2025 Nov.74:101324. Pubmedid: 40753019.
    • Thatikonda S, Chaudhary R, Meshkovska Y, Biernacki M, Slebos RJC, Song X, Hall MS, Lilley K, Pilon-Thomas S, Guevara-Patino JA, Spiess PE, Chahoud J, Amelio AL, Wachter EA, Rodrigues D, Chung CH. PV-10 Triggers Immunogenic Cell Death in Head and Neck Squamous Cell Carcinoma via Endoplasmic Reticulum Stress and Apoptosis. Mol Cancer Ther. 2025 Nov.24(11):1733-1748. Pubmedid: 40552938. Pmcid: PMC12327362.
    • Chen L, Shultz ZP, Sansone M, Fang B, Liu X, Teng M, Schonbrunn E, Lopchuk JM, Chen J. PROTAC-Mediated Degradation of TAF1 Induces Apoptosis in AML Cells and Inhibits Tumor Growth In Vivo. Mol Cancer Ther. 2025 Nov.24(11):1712-1721. Pubmedid: 40376796. Pmcid: PMC12353786.
    • Wang X, Li T, Eljilany I, Soupir A, Radmacher M, Agius P, Sukrithan V, Ratan A, McCarter M, Salhia B, Colman H, Naqash AR, Puzanov I, Arnold S, Marin-Acevedo JA, Ganesan S, Churchman M, Hwu P, Rodriguez PC, Dalton WS, Weiner GJ, Tarhini AA. Multicellular immune ecotypes within solid tumors predict real-world therapeutic benefits with immune checkpoint inhibitors. Nat Commun. 2025 Nov.16(1):9968. Pubmedid: 41233329. Pmcid: PMC12615696.
    • Zhao D, Khatri VM, Nakashima JY, Chadha J, Chatwal M, Zhang J, Ionescu F, Linscott JA, Li R, Poch M, Sexton W, Yu A, Spiess PE, Zemp L, Gilbert SM, Manley B, Yin V, Jain R, Torres-Roca J, Johnstone P, Yamoah K, Grass GD. Early Detection of Metastatic Progression by Circulating Tumor DNA in Patients Undergoing Bladder-preserving Trimodality Therapy. J Urol. 2025 Nov.101097JU0000000000004849. Pubmedid: 41231842.
    • Wang H, Mou Z, Yeo YY, Ge Q, Liu X, Narita Y, Li Z, Wang C, Li W, Zhao KR, Li J, Bu W, Gewurz B, Cohen JI, Teng M, Dai X, Liu X, Jiang S, Zhao B. Epstein-Barr virus exploits desmocollin 2 as the principal epithelial cell entry receptor. Nat Microbiol. 2025 Nov.10(11):2781-2796. Pubmedid: 41006833.
    • Tanvetyanon T, Chen DT, Gray JE. Relationship between PD-L1 Expression and Outcomes of Salvage Treatment Following Durvalumab Consolidation. Clin Lung Cancer. 2025 Oct. Pubmedid: 41238478.
    • Li Z, Liao Y, Ding W, Maestri D, Grote SL, Romero Agosto GA, Murray-Nerger LA, Guo R, Zhao B, Rouskin S, Teng M, Gewurz BE. Epstein-Barr Virus Encoded lncRNAs Control the Viral Lytic Switch. bioRxiv. 2025 Oct. Pubmedid: 41279497. Pmcid: PMC12636365.
    • Adapa SR, Porshe S, Talada DP, Nywening TM, Anderson ML, Shaw TI, Jiang RHY. Spatial Transcriptomics Reveals Distinct Architectures but Shared Vulnerabilities in Primary and Metastatic Liver Tumors. Cancers (Basel). 2025 Oct.17(19). Pubmedid: 41097737. Pmcid: PMC12523610.
    • Jazayeri B, Wang X, Li R. Re: Thomas Dreyer, Simone Brandt, Knud Fabrin, et al. Use of the Xpert Bladder Cancer Monitor Urinary Biomarker Test for Guiding Cystoscopy in High-grade Non-muscle-invasive Bladder Cancer: Results from the Randomized Controlled DaBlaCa-15 Trial. Eur Urol. Eur Urol. 2025 Oct. Pubmedid: 41107180.
    • Gaskill E, Albanyan O, Naqvi SMH, Mo Q, Belfon A, Nishihori T, Faramand R, Lazaryan A, Hansen DK, Khimani F, Mishra A, Nieder M, Perez L, Liu H, Pidala J, Anasetti C, Bejanyan N, Elmariah H. Impact of Obesity and Weight-Based Chemotherapy Dosing Adjustments on Outcomes of Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia. Transplant Cell Ther. 2025 Oct. Pubmedid: 41115629.
    • Chaudhary R, Moorhead G, Park R, Li J, Schell MJ, Song X, Tan A, Slebos RJC, Biernacki MI, Freeman SS, Thatikonda S, Meshkovska Y, Hernandez-Prera J, Kirtane K, Guevara-Patino JA, Amelio AL, Rocco JW, Danysh BP, Bonomi M, Saba NF, Haradhvala NJ, Getz G, Chung CH. Long-term Survival and Molecular Biomarker Evaluation of a Phase II Cetuximab and Nivolumab Clinical Trial in Recurrent/Metastatic Head and Neck Cancer. Clin Cancer Res. 2025 Oct. Pubmedid: 41117857. Pmcid: PMC12667737.
    • Ho E, De Cecco L, Eschrich SA, Cavalieri S, Sedor G, Hoebers F, Brakenhoff RH, Scheckenbach K, Poli T, Yang K, Scarborough JA, Nellore S, Campbell S, Woody N, Chan T, Miller J, Silver N, Koyfman S, Bates J, Caudell JJ, Kattan MW, Licitra L, Torres-Roca JF, Scott JG. Personalized treatment in HPV+ oropharynx cancer using genomic adjusted radiation dose. J Clin Invest. 2025 Oct.135(19). Pubmedid: 40996827. Pmcid: PMC12483556.
    • Dickey BL, Dube Mandishora RS, Sirak B, Fan W, Isaacs-Soriano K, Reich RR, Schell MJ, Lazcano-Ponce E, Villa LL, Giuliano AR. Persistence and clearance of oral human papillomavirus among a multi-national cohort of men. Nat Commun. 2025 Oct.16(1):8816. Pubmedid: 41044066. Pmcid: PMC12494861.
    • DeSomma A, Maletz S, Basinski TL, Morales R, de Castria TB, Bloomston M, Chen DT, Douglas WG, Huguet KL, Jeong D, Jiang K, Kim DW, Luthra A, Pimiento JM, Rajasekhara S, Velanovich V, Park MA, Shields GS, Slavich GM, Permuth JB. Lifetime stressor exposure and depression among patients with pancreatic cancer: insights from the Florida Pancreas Collaborative. BMC Cancer. 2025 Oct.25(1):1530. Pubmedid: 41062956. Pmcid: PMC12506433.
    • Maura F, Bergsagel PL, Ziccheddu B, Kumar S, Maclachlan K, Derkach A, Garces JJ, Firestone R, Braggio E, Asmann Y, Durante M, Diamond BT, Papadimitriou M, Hultcrantz M, Marella A, Castellano G, Maeda A, Lionetti M, Matera A, Pioggia S, Da Vià MC, de Magistris C, Leongamornlert D, DeAvila D, Sudalagunta PR, Canevarolo RR, Siegel EM, Agius P, Teer J, McPherson A, Yamashita Y, Silva AS, Blaney P, Baz R, Patel KK, Campbell P, Morgan G, Fonseca R, Landgren O, Orlowski RZ, Shain KH, Bolli N, Usmani S, Rajkumar SV. Genomics Define Malignant Transformation in Myeloma Precursor Conditions. J Clin Oncol. 2025 Oct.JCO2501733. Pubmedid: 41061199. Pmcid: PMC12614327.
    • Choi H, Sutton SK, Witte D, Pastore N, Wells KJ, Zebrack BJ, Forsyth P, Byrne MM, Reblin M. The CARING intervention for neuro-oncology family caregivers: Randomized controlled trial feasibility, eSNAP/caregiver navigation engagement, and acceptability. Neurooncol Pract. 2025 Oct.12(5):839-849. Pubmedid: 41080195. Pmcid: PMC12508752.
    • Hesterberg RS, Davis JT, Handoo KJ, Elmarsafawi AG, Augello AC, Cheng CH, Atkins R, Lee DH, Yang C, Yao J, Patel KR, Mediavilla-Varela M, Pinilla-Ibarz J, Soto-Palma C, Locke FL, Song X, Wang X, Berglund AE, Rodriguez PC, Knittel G, Flümann R, Reinhardt HC, Shaw TI, Yu X, Niedernhofer LJ, Cleveland JL. Lymphoma accelerates T cell and tissue aging. Cancer Cell. 2025 Oct.43(10):1917-1936.e8. Pubmedid: 40845845.
    • Schmitz J, Gaskill E, Price S, Cao B, Kim J, Baluch A, Klinkova O, Faramand R, Mishra A, Perez L, Khimani F, Lazaryan A, Ochoa-Bayona JL, Liu H, Mirza AS, Nieder M, Anasetti C, Nishihori T, Pidala JA, Bejanyan N, Elmariah H. Letermovir reduces cytomegalovirus in HLA-matched and mismatched allogeneic hematopoietic cell transplant patients receiving post-transplant cyclophosphamide. Bone Marrow Transplant. 2025 Oct.60(10):1383-1386. Pubmedid: 40617898.
    • Park R, Rind F, Kristoff T, Li J, Schell M, Slebos RJC, Thatikonda S, Chaudhary R, Biernacki MI, Meshkovska Y, Kaldas D, Kim HS, Farinhas J, Hernandez-Prera J, Kirtane K, Hall MS, Amelio AL, Rocco JW, Bhateja P, Steuer C, Bonomi M, Saba NF, Chung CH. Evaluation of Neutrophil to Lymphocyte Ratio in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma Treated With a Combination of Cetuximab and Nivolumab in a Phase II Clinical Trial. Am J Clin Oncol. 2025 Sep. Pubmedid: 40905435.
    • Elmariah H, Kim J, Gonzalez R, DiMaggio E, Sansil S, Mishra A, Faramand R, Perez L, Lazaryan A, Mirza AS, Khimani F, Liu H, Ochoa-Bayona JL, Nieder M, Perna F, Figura N, Robinson TJ, Nishihori T, Anasetti C, Pidala JA, Bejanyan N. Phase II Trial of Reduced-Intensity Fludarabine, Melphalan, and Total Body Irradiation Conditioning With Haploidentical Donor Peripheral Blood Stem Cell Transplant. Am J Hematol. 2025 Sep.100(9):1665-1669. Pubmedid: 40492500.
    • Jeong D, Richards AR, Jean-Baptiste E, Gomez MF, Thomas KL, Mo Q, Gigic B, Figueiredo JC, Li CI, Shibata D, Toriola AT, Byrd DA, Ulrich CM, Stewart PA, Siegel EM, Kresovich JK. Comparison of volumetric and single-slice computed tomography body composition metrics for colorectal cancer survival. Eur J Radiol. 2025 Sep.190:112241. Pubmedid: 40532592.
    • Davis EW, Park MA, Basinski TL, Arnoletti JP, Bloomston M, Carson TL, Biachi De Castria T, Chen DT, Cortizas EM, Crowder SL, Genilo-Delgado M, Douglas WG, Huguet KL, Jiang K, Hodul PJ, Karolak A, Kim DW, Koomen JM, Menon AA, Mo Q, Mok SR, Molina-Vega MA, Moreno-Urazan L, Ahmed S, Parker NH, Pimiento JM, Rasool G, Sparks LM, Stewart PA, Tassielli AF, Teer JK, Trevino JG, Velanovich V, Wang X, Whelan CJ, Judge SM, Judge AR, Fleming JB, Malafa MP, Jeong D, Permuth JB. The Impact of Edema on Skeletal Muscle Changes among Patients with Pancreatic Ductal Adenocarcinoma. Cancer Epidemiol Biomarkers Prev. 2025 Sep.34(9):1609-1617. Pubmedid: 40553455.
    • Shepard A, Lester DK, Troutman S, Hoxha S, Khaled WT, Smith ESJ, Park TJ, Buffenstein R, Du D, Teng M, Dengler-Crish CM, Tsai KY, Flores ER, Ventura A, Kissil JL. An Autochthonous Model of Lung Cancer Identifies Requirements for Cellular Transformation in the Naked Mole-Rat. Cancer Discov. 2025 Sep. Pubmedid: 40920097. Pmcid: PMC12486303.
    • Byrd DA, Gomez MF, Hogue SR, Burns JR, Smith N, Sampson J, Loftfield E, Wolf PG, Wan Y, Warner A, Hicks B, Dagnall C, Jones K, Kim Y, Xu J, Shi J, Sinha R, Vogtmann E. Associations of the Colon Tissue Microbiome and Circulating Bile Acids With Colorectal Adenoma Among Average-Risk Women. Cancer Med. 2025 Sep.14(18):e71048. Pubmedid: 40937639. Pmcid: PMC12426762.
    • Arabzadeh M, Tang YH, Colin-Leitzinger C, Marzban S, Walgenbach D, Morganti S, Mahaganapathy V, Harper E, Teng M, Kresovich JK, Washington I, Parsons HA, Garber JE, West J, Ganesan S, Khiabanian H, Gillis N. Clonal Hematopoiesis Dynamics and Evolutionary Fitness During Cancer Treatment Impact Clinical Outcomes. medRxiv. 2025 Sep. Pubmedid: 40950448. Pmcid: PMC12424905.
    • Liu X, Tang YH, Blachly J, Edge S, Jakubek YA, McCarter M, Naqash AR, Nepple KG, Osman A, Reilley MJ, Riedlinger G, Salhia B, Schneider BP, Shriver C, Churchman ML, Rounbehler RJ, Teer JK, Gillis N, Teng M. qcCHIP: an R package to identify clonal hematopoiesis variants using cohort-specific data characteristics. Bioinformatics. 2025 Sep.41(9). Pubmedid: 40973027. Pmcid: PMC12466928.
    • Meads MB, Zhao X, Noyes DR, Sudalagunta P, Achille A, Zhang C, Renatino Canevarolo R, Silva M, Magaletti D, DeAvila D, Toska S, Oates A, Lastorino D, Idiaquez DW, Song J, Sansil S, Yoder SJ, Grajales-Cruz AF, Blue BJ, Freeman CL, Kim J, Alsina M, Brayer J, Siqueira Silva A, Song X, Shain KH, Baz RC. Target antigen and plasma cell phenotype are critical factors for sensitivity to response-adapted daratumumab therapy. Blood. 2025 Sep. Pubmedid: 40983035.
    • Robinson LA, Bryant S, Sun X, Kaki MS, Freyaldenhoven ST, Schwer T, Bailey A, Kim Y. Implantation of polyglycolic acid mesh over lung resection staple lines to prevent air leaks. JTCVS Tech. 2025 Aug.32:163-171. Pubmedid: 40814658. Pmcid: PMC12348291.
    • Rishi A, Albuquerque KV, Jhingran A, Donovan EK, Horne ZD, Ludwig MS, Pathak P, Goldsberry R, Glaser SM, Garg A, Yin V, Fernandez DC, Beriwal S, Ahmed KA, Montejo ME. Definitive intensity-modulated radiotherapy for organ preservation in vulvar cancer: A multicenter study. Gynecol Oncol. 2025 Aug.199:1-9. Pubmedid: 40513383.
    • Noller K, Botsis T, Camara PG, Ciotti L, Cooper LA, Goecks J, Griffith M, Haas BJ, Ideker T, Karchin R, Kontos D, Lai J, Marcus D, Meyer CA, Naegle K, Pati S, Peters B, Pratt D, Raphael BJ, Reich M, Savova GK, Wright C, Fertig EJ, Bakas S. Informatics at the Frontier of Cancer Research. Cancer Res. 2025 Aug.85(16):2967-2986. Pubmedid: 40600473. Pmcid: PMC12355178.
    • Giuliano AR, Beltrame A, Villa LL, Lazcano-Ponce E, Santana-Bagur J, Allen-Leigh B, Portillo-Romero AJ, Sahasrabuddhe VV, House MG, Brofsky E, Galan de Paula L, Carvalho da Silva R, Schell MJ, Rathwell J, Isaacs-Soriano K, Fan W, Mello C, Ellsworth GB, Wilkin T. Design of a multicenter, randomized, double-blinded, placebo-controlled phase III trial evaluating the 9-valent human papillomavirus (HPV) vaccine to prevent persistent oral HPV infection in men living with human immunodeficiency virus: ULACNet trial 201. Vaccine. 2025 Aug.61:127447. Pubmedid: 40609265.
    • Tarhini AA, Obermayer A, Lee SJ, LaFramboise WA, Hodi FS, Karunamurthy AD, Eljilany I, Chen DT, Hwu P, El Naqa IM, Streicher H, Sondak VK, Storkus WJ, Butterfield LH, Shaw TI, Kirkwood JM. Integrative Immune Signature of Complementary Circulating and Tumoral Biomarkers Maximizes the Predictive Power of Adjuvant Immunotherapeutic Benefits in High-risk Melanoma. Clin Cancer Res. 2025 Aug.31(15):3249-3258. Pubmedid: 40392969. Pmcid: PMC12316551.
    • Hatoum F, Fazili A, Miller JW, Wang X, Yu X, Lu X, S Johnson J, Spiess PE, Chahoud J. Current Role and Future Frontiers of Spatial Transcriptomics in Genitourinary Cancers. Cancers (Basel). 2025 Aug.17(17). Pubmedid: 40940870. Pmcid: PMC12427188.
    • Yin J. Narrative Review of the Use of Genomic-Adjusted Radiation Dose (GARD) in Radiotherapy. Cancers (Basel). 2025 Aug.17(16). Pubmedid: 40867280. Pmcid: PMC12384496.
    • Piña Y, Law V, Sahebjam S, Tran N, Siddarajappa N, Li J, Mo Q, Phadke MS, Arrington J, Macaulay R, Mokhtari S, Evernden B, Ahmed KA, Smalley I, Yu M, Smalley KSM, Forsyth PA. Phase IB Study of Avelumab and Whole Brain Radiotherapy (WBRT) in Patients with Leptomeningeal Disease (LMD) from Solid Tumors: Results and Molecular Analyses. Neurooncol. 2025 Aug. Pubmedid: 40888040.
    • Hoogland CE, Sutton SK, Fennell BS, Simmons VN, Vinci C, Naqa IE, Salloum RG, Shete SS, Hembree T, Vidrine DJ, Vidrine JI. Early Treatment Engagement and Long-Term Smoking Abstinence Among Women With Cervical Intraepithelial Neoplasia or Cervical Cancer. AJPM Focus. 2025 Aug.4(4):100361. Pubmedid: 40673008. Pmcid: PMC12264617.
    • Yao S, Li T, Davis JT, Shaw TI, Yu X, Wang X. SmartImpute is a targeted imputation framework for single-cell transcriptome data. Cell Rep Methods. 2025 Aug.5(8):101122. Pubmedid: 40763742. Pmcid: PMC12461658.
    • Obermayer A, Davis J, Talada DP, Teng M, Eschrich S, Yin V, Spakowicz D, Dhrubo D, Rounbehler RJ, Churchman ML, Tarhini AA, Wang X, Gupta S, Markowitz J, Goecks J, Li R, Rodriguez-Pessoa R, Manley BJ, Tan AC, Grass GD, Chen DT, Shaw TI. ShinyEvents: harmonizing longitudinal data for real world survival estimation. Res Sq. 2025 Aug. Pubmedid: 40799741. Pmcid: PMC12340904.
    • Ahmed KA, Kim Y, Armaghani AJ, Arrington JA, Costa RL, Czerniecki BJ, Diaz R, Dowell RA, Extermann M, Forsyth PA, Lee KT, Loftus L, Mills MN, Phuoc VH, Rosa M, Soliman HH, Sam CS, Washington IR, Soyano AE, Han HS. Phase II trial of brain MRI surveillance in stage IV breast cancer. Neurooncol. 2025 Jul.27(6):1550-1558. Pubmedid: 39851040. Pmcid: PMC12309701.
    • Morse B, Jeong D, Ahmed A, Kim J, Spiess P, Chahoud J. Preoperative prediction of high-risk lymph nodes in penile cancer: Graafland criteria vs radiomics. BJU Int. 2025 Jul.136(1):45-46. Pubmedid: 40130666.
    • Zhao Y, Amorrortu RP, Hicks JK, Garcia MA, Haura EB, Yin J, Vadaparampil ST, Rollison DE. An examination of factors associated with disparities in clinical trial eligibility guided by the Socioecological Model. Cancer. 2025 Jul.131(13):e35944. Pubmedid: 40530674. Pmcid: PMC12263167.
    • Veith T, Beck R, Tagal V, Li T, Alahmari S, Cole J, Hannaby D, Kyei J, Yu X, Maksin K, Schultz A, Lee H, El Naqa I, Eschrich S, Ji HP, Diaz A, Andor N. CLONEID: A Framework for Longitudinal Integration of Phenotypic and Genotypic Data to Monitor and Steer Subclonal Dynamics. bioRxiv. 2025 Jul. Pubmedid: 40631300. Pmcid: PMC12236826.
    • Echevarria M, Park R, Caudell JJ, Kim Y, Yang GQ, Kirtane K, Chaudhary R, Kumar S, Amelio AL, Giuliano AR, Chung CH. Plasma Cell-Free Human Papillomavirus DNA and Oral Gargle HPV DNA in Patients with HPV-Related Oropharyngeal Cancer Treated with Radiotherapy. Cancer Res Commun. 2025 Jul.5(7):1194-1202. Pubmedid: 40643202. Pmcid: PMC12281097.
    • Sallman DA, Komrokji RS, Dezern AE, Sebert M, Garcia-Manero G, Rahmé R, Winer ES, Lehmann-Che J, Roboz GJ, Madelaine I, Sekeres MA, Peterlin P, Chan O, Beyne-Rauzy O, Kuykendall A, Recher C, McLemore A, Stamatoullas A, Zhang L, Willems L, Mo Q, Raffoux E, Nardelli L, Berthon C, Al Ali NH, Quesnel B, Padron E, Kantarjian HM, List AF, Ades L, Lancet JE, Fenaux P, Cluzeau T. Long-term follow-up and combined Phase 2 results of eprenetapopt and azacitidine in patients with TP53 mutant MDS/AML. Hemasphere. 2025 Jul.9(7):e70164. Pubmedid: 40657305. Pmcid: PMC12255903.
    • Shen S, Yin J. Bayesian mediation analysis using patient-reported outcomes from AI chatbots to infer causal pathways in clinical trials. PLoS One. 2025 Jul.20(7):e0326517. Pubmedid: 40705787. Pmcid: PMC12289003.
    • Garcia M, Geiss C, Blackwell R, Maconi ML, Amorrortu RP, Tapia-Kwan E, Turner K, Fuzzell L, Zhao Y, Eschrich SA, Rollison DE, Vadaparampil ST. A Formative Evaluation of Interventions to Enhance Clinical Trial Diversity Guided by the Socioecological Model. Cancers (Basel). 2025 Jul.17(14). Pubmedid: 40723166. Pmcid: PMC12293947.
    • Yu X, Jain MD, Menges MA, Cen L, Noble JD, Atkins R, Mohammad TJ, Bachmeier CA, Naderinezhad S, Reid K, Corallo S, Yoder SJ, Zhang C, Zhang L, Miranda JA, Shah B, Chavez JC, Hesterberg RS, Delgado LC, Savid-Frontera C, Rodriguez PC, Cleveland JL, Wang X, Davila ML, Locke FL. Comparison of axicabtagene ciloleucel and tisagenlecleucel patient CAR-T cell products by single-cell RNA sequencing. J Immunother Cancer. 2025 Jul.13(7). Pubmedid: 40730421. Pmcid: PMC12306477.
    • Ugolini A, De Leo A, Yu X, Scirocchi F, Liu X, Peixoto B, Scocozza D, Pace A, Perego M, Gardini A, D'Angelo L, Liu JKC, Etame AB, Rughetti A, Nuti M, Santoro A, Vogelbaum MA, Conejo-Garcia JR, Rodriguez PC, Veglia F. Functional Reprogramming of Neutrophils within the Brain Tumor Microenvironment by Hypoxia-Driven Histone Lactylation. Cancer Discov. 2025 Jun.15(6):1270-1296. Pubmedid: 40014923. Pmcid: PMC12133432.
    • Eschrich SA, Torres-Roca JF. In Reply to Li. Int J Radiat Oncol Biol Phys. 2025 Jun.122(2):513-514. Pubmedid: 40382168.
    • Gao H, Wong SQR, Subel E, Huang YH, Lee YC, Hayashi K, Alonzo ME, Karabicici M, Hoi XP, Kasabyan A, Mo Q, Melchiode Z, El-Zaatari Z, Shen S, Satkunasivam R, Nikolos F, Chan KS. Caspase-1-dependent pyroptosis converts αSMA+ CAFs into collagen-IIIhigh iCAFs to fuel chemoresistant cancer stem cells. Sci Adv. 2025 Jun.11(24):eadt8697. Pubmedid: 40498841. Pmcid: PMC12154229.
    • Tanvetyanon T, Joshi U, Chen DT, Gray JE. Timeliness of Newer Targeted Therapy and Survival in Lung Cancer: A Population-Based Analysis. JCO Oncol Pract. 2025 Jun.OP2400936. Pubmedid: 40472300.
    • Xu X, Liu X, Dollar JJ, Liu X, Jasani N, Posorske B, Sriramareddy SN, Jarajapu V, Kuznetsoff JN, Sinard J, Bennett RL, Licht JD, Smalley KSM, Harbour JW, Yu X, Karreth FA. A multi-step immune-competent genetic mouse model reveals phenotypic plasticity in uveal melanoma. bioRxiv. 2025 Jun. Pubmedid: 40502063. Pmcid: PMC12157397.
    • May AM, Kadomoto S, Williams C, Soupir AC, The S, McGue JJ, Robinson T, Shelley G, Hayes MT, Fridley BL, Balasi JA, Ramos Echevarria PM, Dhillon J, Nallandhighal S, Acharyya S, Chen L, Aldous J, Schurman N, Baladandayuthapani V, Frankel TL, Salami SS, Manley BJ, Mehra R, Udager AM, Keller ET. Spatial analysis reveals a novel inflammatory tumor transition state which promotes a macrophage-driven induction of sarcomatoid renal cell carcinoma. bioRxiv. 2025 Jun. Pubmedid: 40661608. Pmcid: PMC12259133.
    • Xu X, Chadourne M, Soto-Vargas Z, Jarajapu V, Yao J, Yu X, Karreth FA. FRA1 drives melanoma metastasis through an actionable transcriptional network. bioRxiv. 2025 Jun. Pubmedid: 40661443. Pmcid: PMC12258986.
    • Doerfler R, Chen J, Kim C, Smith JD, Harris M, Singh KB, Isett B, Dadey RE, Brown DD, Lee AV, Wang X, Spector ME, Kim S, Sridharan S, Contrera K, Smith K, Reeder C, Lyons M, Luo J, Liu S, Zandberg DP, Skinner HD, Zervantonakis IK, Vujanović L, Ferris RL, Seethala RR, Zevallos JP, Luke JJ, Bao R. Integrating Artificial Intelligence-Driven Digital Pathology and Genomics to Establish Patient-Derived Organoids as a Novel Alternative Model for Drug Response in Head and Neck Cancer. bioRxiv. 2025 Jun. Pubmedid: 40667087. Pmcid: PMC12262215.
    • Peeri NC, Teer JK, Thompson ZJ, Nabors LB, Brooks M, Sologon CM, Williams SL, Egan KM. Glioma grade and mortality in relation to sequence variation in the mitochondrial genome. Cancer Genet. 2025 Jun.294-295:171-180. Pubmedid: 40382795. Pmcid: PMC12124938.
    • Fenlon J, Van Bibber N, Mahlow J, Yamoah K, Soupir AC, Nguyen JV, Moran Segura C, Spivak AM, Knudsen BS, Zhou Q, Hu-Lieskovan S, Puri S, Zhang W, DeRose YS, Suneja G, Coghill AE. Human Immunodeficiency Virus-Associated Differences in the Tumor Immune Microenvironment of Lung, Breast, and Prostate Cancers. Cancer Epidemiol Biomarkers Prev. 2025 Jun.34(6):860-867. Pubmedid: 40183760. Pmcid: PMC12133412.
    • Gamal W, Goedhart NB, Simon-Molas H, Mediavilla-Varela M, Uriepero-Palma A, Peters FS, Maharaj K, Chavez JC, Powers JJ, Obermayer A, Shaw TI, Conejo-Garcia JR, Rodriguez PC, Sahakian E, Pinilla-Ibarz J, Kater AP. Mitigating T-cell mitochondrial dysfunction in CLL to augment CAR T-cell therapy: evaluation in an immunocompetent model. Blood Adv. 2025 May.9(10):2511-2529. Pubmedid: 39938006. Pmcid: PMC12148389.
    • Coghill AE, Van Bibber N, Baiocchi RA, Arnold SM, Riedlinger G, Schneider BP, Zhang Y, Suneja G, Gomez Fontela M, Abate-Daga D, Teer JK. Elevated Tumor Mutation Burden in Cancer Patients with Underlying HIV Infection: Data from the Oncology Research Information Exchange Network (ORIEN). Cancer Epidemiol Biomarkers Prev. 2025 May.34(5):774-779. Pubmedid: 40019488. Pmcid: PMC12048233.
    • Yu J, Laborde JM, Park R, Shahzad M, Kim Y, Cheon J, Imanirad I, Kim RD, Biachi de Castria T, Nardella NL, Malafa M, Denbo JW, Fleming JB, Hoffe SE, Frakes JM, Sinnamon AJ, Pimiento JM, Hodul PJ, Kim DW. Association of Pathologic Response and Adjuvant Chemotherapy with Survival in Resected Pancreatic Ductal Adenocarcinoma Following Neoadjuvant Therapy. Cancers (Basel). 2025 May.17(11). Pubmedid: 40507279. Pmcid: PMC12153592.
    • Lantz AE, Gordián ER, Rosa M, Rodríguez Ruíz M, Johnson JO, Gebert R, Bahr A, Chen DT, Dutil J, Li J, Oliveras Torres JA, Saavedra HI, Eschrich SA, Flores I, Cress WD. Creation and Characterization of a Breast Cancer Tissue Microarray Including Black and White Patients from Florida and Hispanic Patients from Puerto Rico and Florida. Cancer Res Commun. 2025 May.5(5):804-813. Pubmedid: 40309949. Pmcid: PMC12082392.
    • Soupir A, Ospina OE, Hampton O, Churchman M, Radmacher M, Hedges D, McKean D, Agius P, Zeeshan S, Seligson ND, Pollock R, Liebner D, Chen JL, Tinoco G, Salhia B, McCarter M, Wilky BA, Miller BJ, Cavnar MJ, Groundland JS, Schneider BP, Riedlinger G, Edge SB, Moskaluk CA, Cardona K, Naqash AR, Gonzalez RJ, Mullinax JE, Joyce DM, Binitie O, Douglas Letson G, Naghavi AO, Druta M, Reed DR, Siegel EM, Teer JK, Fridley BL, Brohl AS. Genomic, transcriptomic, and immunogenomic landscape of over 1300 sarcomas of diverse histology subtypes. Nat Commun. 2025 May.16(1):4206. Pubmedid: 40328759. Pmcid: PMC12055966.
    • Wang C, Yu X, Teer JK, Yao J, Du D, Liu X, Thompson ZJ, Wang MH, Welsh EA, Memon D, Chan TA, Makarov V, Anadon CM, Saeed L, Boyle TA, Fang B, Koomen JM, Cox C, Landin AM, Yoder SJ, Kim S, Chen DT, Pilon-Thomas SA, Conejo-Garcia JR, Antonia SJ, Haura EB, Creelan BC. Impaired T cell and neoantigen retention in time-serial analysis of metastatic non-small cell lung cancer in patients unresponsive to TIL cell therapy. Nat Cancer. 2025 May.6(5):801-819. Pubmedid: 40341231.
    • Ahmed KA, Quick AM, Chon HS, Chern JY, Bixel K, Kim Y, Li J, Montejo ME, Dowell RA, Kim S, Fernandez DC, Lam CA, Hakam A, Rosa M, Shafique M, Shahzad MM, Wenham RM. Atezolizumab and Stereotactic Body Radiation in Metastatic, Recurrent, or Persistent Cervical Cancer: Results From a Phase 2 Multi-Institutional Study. Int J Radiat Oncol Biol Phys. 2025 May. Pubmedid: 40379142.
    • Gatenby RA, Teer JK, Tsai KY, Brown JS. Parallel and convergent dynamics in the evolution of primary breast and lung adenocarcinomas. Commun Biol. 2025 May.8(1):775. Pubmedid: 40399443. Pmcid: PMC12095661.
    • Kirchgaessner R, Watson C, Creason A, Keutler K, Goecks J. Imputing single-cell protein abundance in multiplex tissue imaging. Nat Commun. 2025 May.16(1):4747. Pubmedid: 40404617. Pmcid: PMC12098973.
    • Song X, Yu X, Moran-Segura CM, Xu H, Li T, Davis JT, Vosoughi A, Grass GD, Li R, Wang X. ROICellTrack: a deep learning framework for integrating cellular imaging modalities in subcellular spatial transcriptomic profiling of tumor tissues. Bioinformatics. 2025 May.41(5). Pubmedid: 40199763. Pmcid: PMC12085996.
    • Matejcic M, Teer JK, Hoehn HJ, Diaz DB, Shankar K, Gong J, Nguyen NT, Loroña NC, Coppola D, Fulmer CG, Saglam O, Jiang K, Cress WD, Muñoz-Antonia T, Flores I, Gordián ER, Oliveras Torres JA, Felder SI, Sanchez J, Fleming JB, Siegel EM, Freedman JA, Dutil J, Stern MC, Fridley BL, Figueiredo JC, Schmit SL. Colorectal Tumors in Diverse Patient Populations Feature a Spectrum of Somatic Mutational Profiles. Cancer Res. 2025 May.85(10):1928-1944. Pubmedid: 40126181. Pmcid: PMC12234169.
    • Freeman CL, Noble J, Menges M, Villanueva R, Nakashima JY, Figura NB, Tonseth RP, Idiaquez DW, Skelson L, Smith EC, Abraham-Miranda J, Corallo S, De Avila G, Castaneda Puglianini O, Liu HD, Alsina M, Nishihori T, Shain KH, Baz RC, Blue BJ, Grajales-Cruz A, Koomen JM, Atkins RM, Hansen DK, Siqueira Silva A, Kim J, Balagurunathan Y, Locke FL. Tumor burden quantified by soluble B-cell maturation antigen and metabolic tumor volume determines myeloma CAR-T outcomes. Blood. 2025 Apr.145(15):1645-1657. Pubmedid: 39652773.
    • Renatino Canevarolo R, Sudalagunta PR, Meads MB, Silva M, Zhao X, Magaletti D, Alugubelli RR, DeAvila G, Persi E, Maura F, Bell ET, Bishop RT, Cubitt CL, Sansil SS, Zhang W, Teer JK, Teng M, Yoder SJ, Siegel EM, Shah BD, Nishihori T, Hazlehurst LA, Lynch CC, Landgren O, Hampton O, Gatenby RA, Sullivan DM, Brayer JB, Dalton WS, Cleveland JL, Alsina M, Baz R, Shain KH, Silva AS. Epigenetic Plasticity Drives Carcinogenesis and Multi-Therapy Resistance in Multiple Myeloma. Res Sq. 2025 Apr. Pubmedid: 40321765. Pmcid: PMC12048002.
    • Mokhtari S, Asquith JM, Kareem SS, Bachmeier CA, Pina Y, Faramand RG, Kim Y, Peguero EN, Sahebjam S, Jaffer MH, Iacono DP, Jain MD, Vogelbaum MA, Davila ML, Forsyth PA, Locke FL, Lazaryan A. Intravenous Immunoglobulin (IVIG) for Patients with Severe Neurotoxicity Associated with Chimeric Antigen Receptor T-Cell (CAR-T) Therapy. Int J Mol Sci. 2025 Apr.26(8). Pubmedid: 40332772. Pmcid: PMC12028060.
    • Mishra A, Thapa R, Bigam K, Extermann M, Faramand R, Khimani F, Wang X, Baracos V, Pidala JA. Body Composition Assessment Provides Prognostic Information in Patients With Cancer Affected by Chronic Graft vs. Host Disease. J Cachexia Sarcopenia Muscle. 2025 Apr.16(2):e13759. Pubmedid: 40151989. Pmcid: PMC11950734.
    • Ahmed KA, Kim Y, Kim S, Wang MH, DeJesus M, Arrington JA, Soyano AE, Armaghani AJ, Costa RLB, Loftus LS, Rosa M, Caudell JJ, Diaz R, Etame AB, Tran ND, Soliman H, Czerniecki BJ, Forsyth PA, Yu HM, Han HS. Nivolumab and stereotactic radiosurgery for patients with breast cancer brain metastases: long-term results and biomarker analysis from a non-randomized, open-label, phase Ib study. J Immunother Cancer. 2025 Apr.13(4). Pubmedid: 40295143. Pmcid: PMC12039042.
    • Schmit SL, Loroña NC, Sobieski D, Matejcic M, Nguyen NT, Hoehn HJ, Diaz DB, Shankar K, Cockman EM, Jean-Baptiste E, Tsai YY, Buchalter RB, Brito K, Wilson R, Coppola D, Fulmer C, Saglam O, Tassielli AF, Beato F, Dai R, Freedman JA, Purrington K, Hu B, Mcgrail D, Gibson H, Jiang K, Muñoz-Antonia T, Flores I, Gordian E, Oliveras Torres JA, Cheng I, Van Blarigan EL, Felder SI, Sanchez JA, Fleming JB, Siegel EM, Cress D, Thompson P, Stern MC, Teer JK, Figueiredo JC. Building research infrastructure to advance precision medicine in colorectal cancer. JNCI Cancer Spectr. 2025 Apr.9(3). Pubmedid: 40111849. Pmcid: PMC12140009.
    • Nowicka Z, Rentzeperis F, Tagal V, Teer JK, Ilter D, Beck RJ, Cole JP, Forero Pinto AM, Tejero JD, Scanu E, Veith T, Dominguez-Viqueira W, Maksin K, Carrillo-Perez FM, Gevaert O, Xu X, Karreth FA, Abdalah MA, Fiandaca G, Pasetto S, Prabhakaran S, Schultz A, Ojwang' AME, Barnholtz-Sloan JS, Farinhas JM, Gomes AP, Katira P, Andor N. Interactions between Ploidy and Resource Availability Shape Clonal Evolution in Glioblastoma. Cancer Res. 2025 Apr.85(8):1544-1559. Pubmedid: 39933186.
    • Colin-Leitzinger C, Tang YH, Teng M, Gillis N. Peripheral blood somatic mosaicism and clonal hematopoiesis across ancestry backgrounds. medRxiv. 2025 Mar. Pubmedid: 40166537. Pmcid: PMC11957158.
    • Davila M, Lee SB, Kang YP, Boucher J, Mandula J, Roselli E, Chang D, Jimenez R, Kotani H, Reid K, Vazquez-Martinez J, Beatty N, Goala P, Sierra-Mondragon R, Liu M, Koomen J, Nguyen J, Hussaini M, Shaw T, Wang X, Faramand R, Jain M, Locke F, Rodriguez P, Sailer C, McSain S, Hamid S, Tariq M, Wang J, Abraham-Miranda J. CAR T cell-driven induction of iNOS in tumor-associated macrophages promotes CAR T cell resistance in B cell lymphoma. Res Sq. 2025 Mar. Pubmedid: 40235478. Pmcid: PMC11998770.
    • Miyagi H, Yu X, Peak T, Dhillon J, Le C, Wang X, Yoder S, Marchion D, Lu X, Pettaway C, Moran Segura C, Zhang C, Roman Souza G, Yu A, Zemp L, Spiess P, Chahoud J. Progressive T cell exhaustion and predominance of aging tissue associated macrophages with advancing disease stage in penile squamous cell carcinoma. Sci Rep. 2025 Mar.15(1):7703. Pubmedid: 40044748. Pmcid: PMC11882776.
    • Wang X, Li T, Slebos RJC, Chaudhary R, Guevara-Patino JA, Bonomi M, Saba NF, Chung CH. Clinical significance of peripheral T-cell repertoire in head and neck squamous cell carcinoma treated with cetuximab and nivolumab. Cancer Immunol Immun. 2025 Mar.74(4):142. Pubmedid: 40056190. Pmcid: PMC11890688.
    • Rajagopal PS, Reid S, Fan R, Venton L, Weidner A, Roberson ML, Vadaparampil S, Wang X, Yoder S, Rosa M, Sanders M, Gonzalez-Ericsson P, Hirbo J, Whisenant JG, Pietenpol J, Ye F, Pal T, Lehmann BD. Population-specific patterns in assessing molecular subtypes of young black females with triple-negative breast cancer. NPJ Breast Cancer. 2025 Mar.11(1):28. Pubmedid: 40069179. Pmcid: PMC11897140.
    • Yang M, Nebozhyn MV, Schell MJ, Gandhi N, Pflieger L, Loboda A, Pledger WJ, Soundararajan R, Maurin M, Wang H, Silva JR, Alden A, Coppola D, Elliott A, Sledge G, Khushman M, Lou E, Goel S, Yeatman TJ. Identifying distinct prognostic and predictive contributions of tumor epithelium versus tumor microenvironment in colorectal cancer. BMC Cancer. 2025 Mar.25(1):441. Pubmedid: 40075322. Pmcid: PMC11899100.
    • Vinci C, Sutton SK, Yang MJ, Jones SR, Kumar S, Wetter DW. Proximal Effects of a Just-in-Time Adaptive Intervention for Smoking Cessation With Wearable Sensors: Microrandomized Trial. JMIR Mhealth Uhealth. 2025 Mar.13:e55379. Pubmedid: 40106803. Pmcid: PMC11966069.
    • Bari S, Matejcic M, Kim RD, Xie H, Sahin IH, Powers BD, Teer JK, Chan TA, Felder SI, Schmit SL. Practice Patterns and Survival Outcomes of Immunotherapy for Metastatic Colorectal Cancer. JAMA Netw Open. 2025 Mar.8(3):e251186. Pubmedid: 40111368. Pmcid: PMC11926646.
    • Berglund AE, Puskas J, Yoder SJ, Smith AT, Marchion DC, Qin D, Mulé JJ, Torres-Roca JF, Eschrich SA. Evaluating the Radiation Sensitivity Index and 12-Chemokine Gene Expression Signature for Clinical Use in a CLIA Laboratory. Cancer Res Commun. 2025 Mar.5(3):389-397. Pubmedid: 39932296. Pmcid: PMC11873780.
    • Poudel R, Dougan SO, Yates H, Sawyer L, Martinez U, Brandon KO, Sutton SK, Vidrine DJ, Ritterband LM, Wiseman KP, Vickerman KA, Turner K, Byrne MM, Yang MJ, Horta M, Brandon TH, Vinci C. Using augmented reality to deliver cue exposure treatment for smoking cessation: App usability findings and protocol for a randomized controlled trial. Contemp Clin Trials. 2025 Mar.150:107827. Pubmedid: 39880329.
    • Ospina OE, Manjarres-Betancur R, Gonzalez-Calderon G, Soupir AC, Smalley I, Tsai KY, Markowitz J, Vallebuona E, Berglund AE, Eschrich SA, Yu X, Fridley BL. spatialGE Is a User-Friendly Web Application That Facilitates Spatial Transcriptomics Data Analysis. Cancer Res. 2025 Mar.85(5):848-858. Pubmedid: 39636739. Pmcid: PMC11873723.
    • Soundararajan R, Maurin MM, Rodriguez-Silva J, Upadhyay G, Alden AJ, Gowda SGB, Schell MJ, Yang M, Levine NJ, Gowda D, Sundaraswamy PM, Hui SP, Pflieger L, Wang H, Marcet J, Martinez C, Bennett RD, Chudzinski A, Karachristos A, Nywening TM, Cavallaro PM, Anderson ML, Coffey RJ, Nebozhyn MV, Loboda A, Coppola D, Pledger WJ, Halade G, Yeatman TJ. Integration of lipidomics with targeted, single cell, and spatial transcriptomics defines an unresolved pro-inflammatory state in colon cancer. Gut. 2025 Mar.74(4):586-602. Pubmedid: 39658263. Pmcid: PMC11885055.
    • Glazar DJ, Sahebjam S, Yu HM, Chen DT, Bhandari M, Enderling H. A sample size analysis of a mathematical model of longitudinal tumor volume and progression-free survival for Bayesian individual dynamic predictions in recurrent high-grade glioma. CPT Pharmacometrics Syst Pharmacol. 2025 Mar.14(3):495-509. Pubmedid: 39737733. Pmcid: PMC11919271.
    • Pidala JA, Kim J, Kalos D, Cutler CS, DeFilipp Z, Flowers ME, Hamilton BK, Chin KK, Rotta M, El Jurdi N, Hamadani M, Ahmed G, Kitko CL, Ponce DM, Sung AD, Tang H, Farhadfar N, Nemecek ER, Pusic I, Qayed M, Rangarajan HG, Hogan WJ, Etra AM, Jaglowski SM. Ibrutinib for therapy of steroid-refractory chronic graft-versus-host disease: a multicenter real-world analysis. Blood Adv. 2025 Mar.9(5):1040-1048. Pubmedid: 39454280. Pmcid: PMC11909441.
    • Sahebjam S, Raval RR, Forsyth PA, Enderling H, Tran ND, Arrington JA, Macaulay R, Perlow HK, Palmer JD, Ghose J, Rajappa P, Giglio P, Li Z, Etame AB, Mokhtari S, Cruz-Chamorro RJ, Bhandari M, Thapa R, Robinson TJ, Chen DT, Yu HM. Phase 1 trial of hypofractionated stereotactic re-irradiation in combination with nivolumab, ipilimumab, and bevacizumab for recurrent high-grade gliomas. Neurooncol Adv. 2025 Feb.7(1):vdaf033. Pubmedid: 40134851. Pmcid: PMC11934552.
    • Han G, Schell MJ, Smith ML, Hopkins L, Liu Y, Carroll RJ, Ory MG. Determining the threshold time in restricted mean survival time analysis for two group comparisons with applications in clinical and epidemiology studies. Am J Epidemiol. 2025 Feb. Pubmedid: 39968729.
    • Permuth J, Park M, Davis E, Alhassan S, Arnoletti J, Basinski T, McKee A, Bloomston M, Carson T, de Castria TB, Chen DT, Cortizas E, Crowder S, Delgado MG, Douglas W, Fleming J, Hodul P, Huguet K, Jiang K, Kim DW, Koomen J, Luthra A, Malafa M, Menon A, Morales R, Merchant N, Meredith K, Mo Q, Molina-Vega M, Moreno-Urazan L, Olumoyin K, Parker N, Pimiento J, Rasool G, Rejniak K, Sansil S, Sparks L, Stewart P, Tassielli A, Teer J, Tran DV, Trevino J, Velanovich V, Whelan C, Jeong D, Judge S, Judge A. Race-based differences in serum biomarkers for cancer-associated cachexia in a diverse cohort of patients with pancreatic ductal adenocarcinoma. Res Sq. 2025 Feb. Pubmedid: 39989973. Pmcid: PMC11844656.
    • Nagy MZ, Plaza-Rojas LB, Boucher JC, Kostenko E, Austin AL, Tarhini AA, Chen Z, Du D, Ojwang' AME, Davis J, Obermayer A, Rejniak KA, Shaw TI, Guevara-Patino JA. Effector T cells under hypoxia have an altered transcriptome similar to tumor-stressed T cells found in non-responsive melanoma patients. J Immunother Cancer. 2025 Feb.13(2). Pubmedid: 40010774.
    • Han HS, Aldrich AL, Garg SK, Weinfurtner RJ, Nguyen JV, Mo Q, Whiting J, Childress J, Soliman H, Costa R, Armaghani A, Soyano A, Kiluk J, Hoover S, Lee MC, Khakpour N, Shenoi N, Jameel Z, Koski GK, Czerniecki BJ. Alteration of the Tumor Microenvironment With Intratumoral Dendritic Cells Before Chemotherapy in ERBB2 Breast Cancer: A Nonrandomized Clinical Trial. JAMA Oncol. 2025 Feb.11(2):119-127. Pubmedid: 39636623. Pmcid: PMC11622104.
    • Wang C, Leong MM, Ding W, Narita Y, Liu X, Wang H, Yiu SPT, Lee J, Zhao KRS, Cui A, Gewurz B, Hammerschmidt W, Teng M, Zhao B. Viral oncogene EBNALP regulates YY1 DNA binding and alters host 3D genome organization. EMBO Rep. 2025 Feb.26(3):810-835. Pubmedid: 39747661. Pmcid: PMC11811279.
    • DePalo DK, Dugan MM, Naqvi SMH, Ollila DW, Hieken TJ, Block MS, van Houdt WJ, Wouters MWJM, Reijers SJM, Asher N, Broman KK, Duncan Z, Anderson M, Gyorki DE, Snow H, Held J, Farma JM, Vetto JT, Hui JYC, Kolbow M, Saw RPM, Lo SN, Long GV, Thompson JF, Kim Y, Karapetyan L, Ny L, van Akkooi ACJ, Bagge RO, Zager JS. A comparison of isolated limb infusion/perfusion, immune checkpoint inhibitors, and intralesional therapy as first-line treatment for patients with melanoma in-transit metastases. Cancer. 2025 Jan.131(1):e35636. Pubmedid: 39522025.
    • Li R, Villa NY, Yu X, Johnson JO, Borjas G, Dhillon J, Moran-Segura CM, Kim Y, Francis N, Dorman D, Powers JJ, Sexton WJ, Spiess PE, Poch MA, Zemp L, Gilbert SM, Zhang J, Pow-Sang JM, Anderson ARA, Li T, Wang X, Grass GD, Burke JM, Dinney CPN, Rodriguez PC, Jain RK, Mulé JJ, Conejo-Garcia JR. Oncolytic immunotherapy with nivolumab in muscle-invasive bladder cancer: a phase 1b trial. Nat Med. 2025 Jan.31(1):176-188. Pubmedid: 39521884.
    • Shaw TI, Pounds S, Cao X, Ma J, Palacios G, Mason J, Perkins S, Wu G, Fan Y, Wang J, Zhou X, Obermayer A, Kinney MC, Kraveka J, Gross T, Sandlund J, Zhang J, Mullighan C, Lim MS, Leventaki V. Comprehensive genomic analysis reveals molecular heterogeneity in pediatric ALK-positive anaplastic large cell lymphoma. Leukemia. 2025 Jan.39(1):199-210. Pubmedid: 39592809.
    • Parker NH, de Cerqueira Santos A, Mintrone R, Turner K, Sutton SK, O'Connor T, Huang J, Lael M, Cruff S, Grassia K, De Vera MT, Bean M, Carmella R, Vadaparampil ST, Vidrine JI. Feasibility, Acceptability, and Outcomes of Project Rally: Pilot Study of a YMCA-Based Pickleball Program for Cancer Survivors. Healthcare (Basel). 2025 Jan.13(3). Pubmedid: 39942445. Pmcid: PMC11817839.
    • Nardella N, Xia BT, Allenson K, Oraiqat A, Fan W, Mo Q, Permuth J, Kim DW, Hodul P. Influence of Coping, Esteem, and Resilience on Caregiver Distress in Pancreatic Cancer Patient-Caregiver Dyads. Healthcare (Basel). 2025 Jan.13(2). Pubmedid: 39857142. Pmcid: PMC11765500.
    • Lazure F, Drapela S, Liu X, Lockhart JH, Kashfi H, Sarigul N, Ilter D, Flores ER, Wang X, Smalley I, Jaeger A, Yu X, Gomes AP. Aging directs the differential evolution of KRAS-driven lung adenocarcinoma. bioRxiv. 2025 Jan. Pubmedid: 39896625. Pmcid: PMC11785146.
    • Mustasam A, Parza K, Ionescu F, Gullapalli K, Paravathaneni M, Kim Y, Sandstrom RE, Al Assaad M, Grass GD, Johnstone P, Eschrich S, Safa H, Chadha J, Roman Souza G, David J, Semaan A, Zacharias NM, Pettaway C, Giuliano AR, Spiess PE, Chahoud J. The Prognostic Role of HPV or p16INK4a Status in Penile Squamous Cell Carcinoma: A Meta-Analysis. J Natl Compr Canc Ne. 2025 Jan.23(2). Pubmedid: 39752880.
    • Sudalagunta PR, Canevarolo RR, Meads MB, Silva M, Zhao X, Cubitt CL, Sansil SS, DeAvila G, Alugubelli RR, Bishop RT, Tungesvik A, Zhang Q, Hampton O, Teer JK, Welsh EA, Yoder SJ, Shah BD, Hazlehurst L, Gatenby RA, Van Domelen DR, Chai Y, Wang F, DeCastro A, Bloomer AM, Siegel EM, Lynch CC, Sullivan DM, Alsina M, Nishihori T, Brayer J, Cleveland JL, Dalton W, Walker CJ, Landesman Y, Baz R, Silva AS, Shain KH. The Functional Transcriptomic Landscape Informs Therapeutic Strategies in Multiple Myeloma. Cancer Res. 2025 Jan.85(2):378-398. Pubmedid: 39476082. Pmcid: PMC11733535.
    • Soupir AC, Hayes MT, Peak TC, Ospina O, Chakiryan NH, Berglund AE, Stewart PA, Nguyen J, Segura CM, Francis NL, Echevarria PMR, Chahoud J, Li R, Tsai KY, Balasi JA, Peres YC, Dhillon J, Martinez LA, Gloria WE, Schurman N, Kim S, Gregory M, Mulé J, Fridley BL, Manley BJ. Increased spatial coupling of integrin and collagen IV in the immunoresistant clear-cell renal-cell carcinoma tumor microenvironment. Genome Biol. 2024 Dec.25(1):308. Pubmedid: 39639369. Pmcid: PMC11622564.
    • Reid S, Fan R, Venton L, Weidner A, Tezak A, Roberson ML, Vadaparampil S, Wang X, Yoder S, Rosa M, Hirbo J, Whisenant JG, Pietenpol J, Rajagopal PS, Lehmann B, Ye F, Pal T. West African Genetic Ancestry and Breast Cancer Outcomes Among Black Women. JAMA Netw Open. 2024 Dec.7(12):e2449798. Pubmedid: 39652347. Pmcid: PMC11629124.
    • Park MA, Gumpper-Fedus K, Krishna SG, Genilo-Delgado MC, Brantley S, Hart PA, Dillhoff ME, Gomez MF, Basinski TL, Mok SR, Luthra AK, Fleming JB, Mohammadi A, Centeno BA, Jiang K, Karolak A, Jeong D, Chen DT, Stewart PA, Teer JK, Cruz-Monserrate Z, Permuth JB. Molecular Pathway and Immune Profile Analysis of IPMN-Derived Versus PanIN-Derived Pancreatic Ductal Adenocarcinomas. Int J Mol Sci. 2024 Dec.25(23). Pubmedid: 39684873. Pmcid: PMC11642437.
    • Karlberg B, Kirchgaessner R, Lee J, Peterkort M, Beckman L, Goecks J, Ellrott K. SyntheVAEiser: augmenting traditional machine learning methods with VAE-based gene expression sample generation for improved cancer subtype predictions. Genome Biol. 2024 Dec.25(1):309. Pubmedid: 39696541. Pmcid: PMC11658131.
    • Lee B, Chehab SS, Fan W, Schell MJ, Kirtane KS, Shah AB. Safety outcomes of pembrolizumab with platinum agent chemotherapy combined with 5-fluorouracil or taxane derivative in head and neck cancer. J Oncol Pharm Pract. 2024 Dec.30(8):1397-1402. Pubmedid: 38043938. Pmcid: PMC11590380.
    • Dhir A, Hayashi M, Bodlak A, Oesterheld J, Loeb DM, Mascarenhas L, Isakoff MS, Sandler ES, Borinstein SC, Trucco M, Lagmay JP, Setty BA, Pratilas CA, Caywood E, Metts J, Yin H, Fridley B, Yin J, Laborde J, Reed DR, Adams DL, Wagner LM. Phase II Trial of Gemcitabine and Nab-Paclitaxel for Recurrent Osteosarcoma with Serial Monitoring Using Liquid Biopsy: A Report from the National Pediatric Cancer Foundation. Clin Cancer Res. 2024 Dec.30(23):5314-5322. Pubmedid: 39360936.
    • Tarhini AA, Eroglu Z, Eljilany I, Zager JS, Gonzalez RJ, Sarnaik AA, Cruse CW, Khushalani NI, De Aquino DB, Abraham E, Acevedo DM, Richards A, Schell MJ, Kalos D, Chen PL, Messina JL, Canton DA, Sondak VK. Neoadjuvant Intratumoral Plasmid IL-12 Electro-Gene-Transfer and Nivolumab in Patients with Operable, Locoregionally Advanced Melanoma. Clin Cancer Res. 2024 Dec.30(23):5333-5341. Pubmedid: 39417680. Pmcid: PMC11611651.
    • Yao S, Li K, Li T, Yu X, Kuan PF, Wang X. GPS-Net: Discovering prognostic pathway modules based on network regularized kernel learning. Am J Hum Genet. 2024 Dec.111(12):2826-2838. Pubmedid: 39510078. Pmcid: PMC11639089.
    • Hänggi K, Li J, Gangadharan A, Liu X, Celias DP, Osunmakinde O, Keske A, Davis J, Ahmad F, Giron A, Anadon CM, Gardner A, DeNardo DG, Shaw TI, Beg AA, Yu X, Ruffell B. Interleukin-1α release during necrotic-like cell death generates myeloid-driven immunosuppression that restricts anti-tumor immunity. Cancer Cell. 2024 Dec.42(12):2015-2031.e11. Pubmedid: 39577420. Pmcid: PMC11631672.

Cambiar el idioma

Si no encuentra la información que busca o si desea programar una cita, llámenos gratis al 1-888-663-3488.

Gracias.

 

 

 

 

Cancel | Cancelar OK